SCHEMBL1775401

SCHEMBL1775401

CN1CCN(c2nccc3sc(S(=O)(=O)Nc4ccccc4)cc23)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.45
LMNA P02545 2/20 0.45
PKM P14618 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HTR6 P50406 7/20 0.44
HTR2A P28223 5/20 0.44
HTR1A P08908 3/20 0.44
HTR7 P34969 3/20 0.44
HTR1D P28221 2/20 0.44
HTR1B P28222 2/20 0.44
CYP1A2 P05177 3/20 0.42
CYP3A4 P08684 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP2D6 P10635 1/20 0.42
HIF1A Q16665 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1774702 0.99 HRH4 (0.44) HRH4LMNAPKMSMN1; SMN2HTR6
SCHEMBL1775441 0.91 HTR6 (0.45) HRH4SMN1; SMN2HTR6HTR2AHTR1A
Hydrochloric Acid SCHEMBL1775491 0.90 HTR6 (0.45) HRH4SMN1; SMN2HTR6HTR2AHTR1A
SCHEMBL1774608 0.89 HTR6 (0.51) LMNAHTR6HTR2AHTR1AHTR7
Hydrochloric Acid SCHEMBL1775137 0.88 HTR6 (0.50) LMNAHTR6HTR2AHTR1AHTR7
SCHEMBL1777202 0.87 HTR6 (0.48) LMNAHTR6HTR2AHTR1AHTR7
Hydrochloric Acid SCHEMBL1775919 0.86 HTR6 (0.47) LMNAHTR6HTR2AHTR1AHTR7
SCHEMBL1776834 0.83 LMNA (0.43) LMNAHTR6HTR2AHTR1AHTR7
Hydrochloric Acid SCHEMBL1775206 0.82 LMNA (0.42) LMNAHTR6HTR2AHTR1AHTR7
SCHEMBL5015937 0.81 HRH4 (0.46) HRH4HTR2AHTR1AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943639-B2 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss PROXIMAGEN LIMITED (GB) 2011-05-17 US claimed